Drug intelligence / Profile preview

methadone + fentanyl

Development stage
Discontinued
Modality
Small Molecules
Administration
Oral, Intravenous, Transdermal, Intranasal, Inhalation, Sublingual, Intramuscular
01

Overview

A combination of two potent synthetic opioids. Methadone is a long-acting synthetic opioid analgesic that works as a full μ-opioid receptor agonist and NMDA receptor antagonist. It's used for severe pain management and as a maintenance treatment for opioid use disorder. Methadone has a long duration of action compared to other opioids, making it effective for preventing withdrawal symptoms in people dependent on opioids. Fentanyl is a powerful synthetic opioid that is similar to morphine but 50 to 100 times more potent. It's prescribed for severe pain management but is also manufactured and used illegally. Fentanyl has become a major contributor to overdose deaths in the United States. When combined, they represent a potentially dangerous drug combination due to their additive central nervous system depressant and respiratory depressant effects. This combination can significantly increase the potential for fatal overdoses.

02

Targets

KOR (Kappa opioid receptor)SIGMAR1 (Sigma non-opioid intracellular receptor 1)MOR (Mu opioid receptor)NMDAR (Glutamate receptor ionotropic, NMDA)DOR (Opioid Receptor Delta 1)NET (Norepinephrine Transporter)SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on methadone + fentanyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methadone + fentanyl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call